How have NEVPF shares performed in 2024?

Abliva AB (publ)'s stock was trading at $0.01 at the beginning of 2024. Since then, NEVPF shares have increased by 0.0% and is now trading at $0.01. View the best growth stocks for 2024 here .

How do I buy shares of Abliva AB (publ)?

Shares of NEVPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:NEVPF

Abliva AB (publ) (NEVPF) Stock Price, News & Analysis

→ Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad)

Free NEVPF Stock Alerts

$0.01

0.00 (0.00%)

(As of 04/16/2024 ET)

Compare

Today's Range: $0.01
▼
$0.01
50-Day Range: $0.01
▼
$0.02
52-Week Range: $0.01
▼
$0.02

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Short Interest

Get Abliva AB (publ) alerts:

Ad Paradigm Press

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Abliva AB (publ) Stock (OTCMKTS:NEVPF)

Abliva AB (publ), a clinical-stage biotech company, develops medicines for the treatment of primary mitochondrial diseases. The company is developing KL1333 that is in Phase 2/3 clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT that is in Phase 1b/2a clinical study for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.

NEVPF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NEVPF Stock News Headlines

March 20, 2024 | barrons.com

Probi AB

January 10, 2024 | seekingalpha.com

IVSXF Investor AB (publ)

April 16, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

October 3, 2023 | investing.com

Interfox Resources publ AB (IFOX)

October 14, 2022 | investing.com

Cell Impact publ AB (CELLI)

January 20, 2022 | nasdaq.com

Abliva AB (publ) (NEVPF)

See More Headlines

Receive NEVPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abliva AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/16/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:NEVPF
CUSIP: N/A
CIK: N/A
Web: www.neurovive.com
Phone: (646) 275-6220
Fax: 46-4-688-883-48
Employees: 8
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-8,450,000.00
Net Margins: N/A
Pretax Margin: -6,314,897.50%
Return on Equity: -63.75%
Return on Assets: -57.93%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 6.60
Quick Ratio: 6.60

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.04 per share
Price / Book: 0.25

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Dr. Ellen K. Donnelly Ph.D. (Age 50)
Chief Executive Officer
Comp: $4.97M
Ms. Catharina Jz Johansson (Age 57)
Deputy CEO, CFO & VP of Investor Relations
Dr. Eskil Elmér M.D. (Age 54)
Ph.D., Chief Scientific Officer & VP of Discovery
Comp: $247k
Daniel Schale
Director of Communications
Dr. Magnus Hansson (Age 48)
Chief Medical Officer and VP of Preclinical & Clinical Development
Mr. Dag Nesse
Vice President of Clinical Operations
Dr. Lars Vedin
Consultant

Key Competitors

View All Competitors

NEVPF Stock Analysis - Frequently Asked Questions

How have NEVPF shares performed in 2024?: Abliva AB (publ)'s stock was trading at $0.01 at the beginning of 2024. Since then, NEVPF shares have increased by 0.0% and is now trading at $0.01.
View the best growth stocks for 2024 here.
How do I buy shares of Abliva AB (publ)?: Shares of NEVPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:NEVPF) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial